Abstract
The pituitary adenylate cyclase-activating polypeptide type-1 receptor (PAC1) has been involved in the survival and differentiation of neuroblasts during development. This study examined the effects of various neurotrophins on the activity of the mouse PAC1 promoter/luciferase reporter constructs in rat PC12 cells and in 8-day-old mouse cerebellar granule cells. In PC12 cells, both differentiating factors such as nerve growth factor (NGF) and mitogens such as epidermal growth factor (EGF) and insulin growth factor-1 (IGF-1) up-regulated PAC1 promoter activity by 2-4-fold in a concentration-dependent manner. Although PACAP differentiated the PC12 cells, it had no effect on the PAC1 promoter and antagonized the stimulatory effect of NGF. In cerebellar granule cells, IGF-1 and brain-derived neurotrophic factor (BDNF) also stimulated the activity of the PAC1 promoter. NGF and IGF-1 increased endogenous PAC1 mRNA levels, and the NGF-induced up-regulation is the result of an increase in transcription from PAC1 promoter instead of an increase in mRNA stability. The mitogen-activated protein kinase (MAPK) kinase inhibitor, PD98059, prevented the transcriptional effects both in PC12 and cerebellar granule cells. Moreover, expression of dominant-negative Ras protein in PC12 cells also prevented the NGF effect. Our results show that the PAC1 promoter can be up-regulated by diverse neurotrophins via an MAPK-dependent pathway and suggest a role for the Ras protein.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Brain-Derived Neurotrophic Factor / pharmacology
-
Cells, Cultured
-
Cerebellum / cytology
-
Cerebellum / drug effects
-
Cerebellum / metabolism
-
Insulin-Like Growth Factor I / pharmacology
-
MAP Kinase Signaling System / drug effects
-
MAP Kinase Signaling System / physiology*
-
Mice
-
Nerve Growth Factor / pharmacology
-
Nerve Growth Factors / pharmacology*
-
Neurons / cytology
-
Neurons / drug effects
-
Neurons / metabolism*
-
Neuropeptides / pharmacology
-
PC12 Cells
-
Phosphatidylinositol 3-Kinases / metabolism
-
Pituitary Adenylate Cyclase-Activating Polypeptide
-
Promoter Regions, Genetic / drug effects*
-
Promoter Regions, Genetic / physiology
-
RNA, Messenger / metabolism
-
Rats
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
-
Receptors, Pituitary Hormone / genetics*
-
Receptors, Pituitary Hormone / metabolism
-
Transcription, Genetic / drug effects
-
Up-Regulation / drug effects
-
ras Proteins / metabolism*
Substances
-
Adcyap1 protein, mouse
-
Adcyap1 protein, rat
-
Adcyap1r1 protein, mouse
-
Adcyap1r1 protein, rat
-
Brain-Derived Neurotrophic Factor
-
Nerve Growth Factors
-
Neuropeptides
-
Pituitary Adenylate Cyclase-Activating Polypeptide
-
RNA, Messenger
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
-
Receptors, Pituitary Hormone
-
Insulin-Like Growth Factor I
-
Nerve Growth Factor
-
Phosphatidylinositol 3-Kinases
-
ras Proteins